These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3946097)

  • 21. Pharmacokinetics of azosemide in patients with T-drain after cholecystectomy.
    Schuchmann HW; Rösch W; Koch U; Maurer HH; Stengl U; Mutschler E
    Arzneimittelforschung; 1992 Jun; 42(6):812-4. PubMed ID: 1418035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL; Barriere SL; Kitt MM; Goldberg MR
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic studies of [14C]-flumecinol in humans.
    Klebovich I; Csetényi J; Kerpel-Fronius S; Vereczkey L
    Arzneimittelforschung; 1987 Mar; 37(3):368-71. PubMed ID: 3593454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of 14C-estazolam in dogs and humans.
    Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
    Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.
    Shah J; Teitelbaum P; Molony B; Gabuzda T; Massey I
    Br J Clin Pharmacol; 1991 Dec; 32(6):761-4. PubMed ID: 1768571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method for the analysis of perhexiline and its hydroxy metabolite in plasma using high-performance liquid chromatography with precolumn derivatization.
    Grgurinovich N
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):75-80. PubMed ID: 9300911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti rats.
    Licari G; Somogyi AA; Milne RW; Sallustio BC
    Xenobiotica; 2015 Jan; 45(1):3-9. PubMed ID: 25050791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose.
    Sallustio BC; Westley IS; Morris RG
    Br J Clin Pharmacol; 2002 Aug; 54(2):107-14. PubMed ID: 12207628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the metabolism of perhexiline in man.
    Cooper RG; Evans DA; Price AH
    Eur J Clin Pharmacol; 1987; 32(6):569-76. PubMed ID: 3653226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady state.
    Jones TE; Morris RG; Horowitz JD
    Br J Clin Pharmacol; 2004 Mar; 57(3):263-9. PubMed ID: 14998422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy.
    Tseng CC; Noordali H; Sani M; Madhani M; Grant DM; Frenneaux MP; Zanda M; Greig IR
    J Med Chem; 2017 Apr; 60(7):2780-2789. PubMed ID: 28277663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of perhexiline maleate (Pexid) and alcohol on rat liver.
    McDonald GS
    Br J Exp Pathol; 1979 Jun; 60(3):294-9. PubMed ID: 475976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid and lysosomal enzymes in human fibroblasts cultured with perhexiline maleate.
    Albouz S; Boutry JM; Dubois G; Bourdon R; Hauw JJ; Baumann N
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):173-7. PubMed ID: 7300921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological properties of "soft drug" derivatives related to perhexiline.
    Marciniak G; Decolin D; Leclerc G; Decker N; Schwartz J
    J Med Chem; 1988 Dec; 31(12):2289-96. PubMed ID: 2903931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid method for the determination of perhexiline in serum using gas-liquid chromatography.
    Cooper JD; Turnell DC
    Ann Clin Biochem; 1980 May; 17(3):155-8. PubMed ID: 6105836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enantioselectivity in the tissue distribution of perhexiline contributes to different effects on hepatic histology and peripheral neural function in rats.
    Licari G; Milne RW; Somogyi AA; Sallustio BC
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00406. PubMed ID: 29864243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caring for patients with acute myocardial ischaemia: the perhexiline maleate experience.
    Stewart S
    Dimens Crit Care Nurs; 1995; 14(3):127-35. PubMed ID: 7781472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe ocular side effects of perhexilene maleate: case report.
    Gibson JM; Fielder AR; Garner A; Millac P
    Br J Ophthalmol; 1984 Aug; 68(8):553-60. PubMed ID: 6743625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.